ASSESSMENT OF KNOWLEDGE, ATTITUDE, AND PRACTICES TOWARDS ADVERSE DRUG REACTION (ADR) REPORTING AMONGST THE COMMUNITY: A QUESTIONNAIRE BASED STUDY.

Main Article Content

Dr. Vaishali Thakare
Dr. Mukta Jain
Ms. Vijetha Hegde
Ms. Sanaz Harsoliya
Mr. Aditya kankal

Keywords

.

Abstract

ADR is defined as “a response to a drug that is noxious and unintended and occurs at dose normally used in a man for prophylaxis, diagnosis or therapy of disease or the modification of physiological function”.1

Abstract 178 | PDF Downloads 114

References

1. Shimizu T, Ikeda Y. [Classification and mechanism of adverse drug reaction]. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:5–9.
2. Suke SG, Kosta P, Negi H. Role of Pharmacovigilance in India: An overview. Online J Public Health Inform. 2015;7(2):e223.
3. Katusiime B, Semakula D, Lubinga SJ. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda. Afr Health Sci. 2016 Jan 18;15(4):1308.
4. Sartori D, Aronson JK, Onakpoya IJ. Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature. Syst Rev. 2020 Dec 13;9(1):180.
5. Sirili N, Kilonzi M, Mwakawanga DL, Mohamedi JA, Thobias JM, Clement A, et al. Awareness, Actions, and Predictors of Actions on Adverse Drug Reaction Reporting among Patients Attending a Referral Hospital in Southern Highland Tanzania. Adv Pharmacol Pharm Sci. 2023;2023.
6. Vigneshwaran E, Harichandana V, Sadiq MMJ, Alavudeen SS, Khan NA, Ahmed T. Knowledge, Attitude and Practice of Community Pharmacists towards Adverse Drug Reactions Reporting. Journal of Young Pharmacists. 2020 Apr 30;12(1):75–80.
7. Ahmad A, Patel I, Balkrishnan R, Mohanta G, Manna P. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study. Perspect Clin Res. 2013;4(4):204.
8. Ali S, Egunsola O, Al-Dossari DS, Al-Zaagi IA. Adverse drug reaction reporting in a large tertiary hospital in Saudi Arabia: results of an incentive strategy. Ther Adv Drug Saf. 2018 Oct 1;9(10):585–90.
9. Avery A, Anderson C, Bond C, Fortnum H, Gifford A, Hannaford P, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess (Rockv). 2011 May;15(20).
10. Srisuriyachanchai W, Cox AR, Kampichit S, Jarernsiripornkul N. Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey. Int J Environ Res Public Health. 2023 Feb 1;20(4)